Do you know the Gold Standard for Making a Platelet Concentrate?
The Red Cross Does, and so does Exo Advantage.
Exo Advantage Offers:
Significant Savings
Superior Solutions for Your Patients
Simple Processes for Your Staff
Increased Capabilities
Research has shown that dose matters. The Exo Advantage protocol focuses on the dose thresholds in peer-reviewed journals.
Finally Get Access to Improved Results at Lower Cost
The current Association for the Advancement of Blood and Biotherapies (AABB) standard and requirements in the U.S. Code of Federal Regulations (CFR) indicate that the processing of whole blood donations into its various therapeutic fractions as administered by the nation’s blood banking industry relies on a two-step centrifugation process with an interim precise decant step.
Our independent consulting partners are experts in blood processing and related protocols.
-
Commercial Platelet Concentrate (PC) and Bone Marrow Aspirate (BMAC) kits do not capture the full potential of cells, platelets, proteins, and exosomes present in the starting sample. We know that the entire dose matters.
-
Better protocols disrupt the industry by being radically affordable as measured by:
Cost per procedure
Cost per billion platelets delivered
Increase over baseline
Or any other independent measure
-
You deserve an elegant, customizable protocol that lets you easily transition from Leukocyte-Poor to Leukocyte-Rich Preps.
Dr. Christopher Kyriakides, NYU Langone, Regenerative Sports Care Institute (RSI), 360 Pain Care and Orthopedics